Asthma Drugs Market Forecast to 2028

Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medications (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringes/Vials, and Others), and Distribution Channels (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)

Report Code : TIPRE00021879 | Region : Global | Industry : Pharmaceuticals | Published Date : 30/Apr/2022

The asthma drugs market is projected to reach US$ 34,136.10 million in 2028 from US$ 24,239.17 million in 2021; it is estimated to grow at a CAGR of 5.0 % during 2021–2028. The report highlights trends prevailing in the market and factors driving the market growth. The asthma drug market growth is attributed to the growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and growing prevalence of physiological disorders harboring asthma. However, unmet medical needs and lack of treatment adherence hamper the asthma drug market growth.

Asthma is a chronic respiratory condition marked by fluctuating airflow restriction, bronchial hyperresponsiveness, and airways inflammation. According to a review paper titled “Impact of Air Pollution on Asthma Outcomes” by Tiotiu et.al., air pollution hampered asthma outcomes in adults and children. Air pollution from traffic, nitrogen dioxide (NO2), and secondhand smoking (SHS) are all substantial risk factors for the development of asthma in children. Asthma symptoms, exacerbations, and decreased lung function can be triggered by exposure to outside pollution.

In the US, exposure to air pollution continues to be associated with asthma. This severe and life-threatening chronic respiratory condition impacts the quality of life of more than ~23 million American citizens. Air pollution can aggravate asthma symptoms, triggering asthma attacks among people. Children with asthma, which affects ~6 million children in the US, are particularly vulnerable to pollution.

A new study financed by the Environmental Protection Agency (EPA) analyzed the link between air pollution and asthma. While experts cannot determine the primary asthma-causing agent due to air pollution, evidence suggests that it suppresses genes that control the immune system to distinguish between an allergen and a hazardous foreign substance, such as a virus or bacteria. The immune system then goes into overdrive, triggering an inflammatory reaction regardless of whether the drug is toxic, resulting in asthma.

Researchers from Stanford University's Children's Center investigated the effect of air pollution on two genes involved in immunological tolerance in children from an area with high levels of pollution. They discovered that short- and long-term exposure to high amounts of carbon monoxide (CO), NO2, and particulate matter) (PM2.5) were linked to changes in these two genes, which caused asthma. These findings focused on the epigenetic impacts of air pollution exposure and could help develop preventative asthma medicines.

Each of these asthma research improved the understanding of asthma in children and supplied crucial information to the EPA that can be used to protect human health and the environment. Through these research works, the drug discovery and development for asthma is being expedited, which is driving the asthma drug market.

Based on medications, the asthma drugs market is bifurcated into quick relief medications and long-term control medications. The long-term control medications segment held a larger market share in 2021; however, the quick relief medications segment is anticipated to register a higher CAGR of the asthma drugs market during the forecast period. Based on route of administration, the asthma drugs market is segmented into inhaled, prefilled syringes/vials, and others. The inhaled segment held the largest share of the market in 2021; however, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period. Based on distribution channels, the market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies segment held the largest share of the market. However, the online pharmacies segment is expected to register the highest CAGR during the forecast period.

The COVID-19 crisis created a public health and economic crisis in many countries worldwide. The pandemic adversely affected a large percentage of the population in the first half of 2020. With the virus affecting the respiratory system primarily, individuals with respiratory disorders were at a considerably higher risk of mortality and complications. For this, various organizations such as the Centers for Disease Control & Prevention, Asthma & Allergy Foundation of America, the World Health Organization, and the European Respiratory Society published guidelines, standards, and norms for patient care, differentiation of COVID-19 from other flu-like diseases, asthma, and allergies, and steps to avoid contracting COVID-19 in an asthmatic patient. Various recommendations were also released, such as stocking up on asthma drugs to prevent the shortage of drugs for asthmatic patients. Various organizations, such as the WHO, concluded that the risk of infection was higher in people with asthma, leading to further exacerbation of asthma. The WHO also mentions that people with asthma who appear more vulnerable to worse outcomes included those who also had chronic obstructive pulmonary disease and people with non-allergic asthma compared to allergic asthma. Older age and non-white ethnicity also appear to confer greater risk, as expected from data from the general population. The European Respiratory Society (ERS) also urged people with asthma to continue using their prescribed medications to control asthma and reduce the risk of experiencing severe COVID-19 complications, leading to an increased demand for asthmatic drugs. A 2021 study aimed to understand the association between asthma and lower respiratory tract involvement and worse clinical scores in children with COVID-19. The study found that lower respiratory tract (LRT) involvement occurred in approximately 1 out of 7 children with COVID-19 presenting with infrequent wheezing. Asthma/recurrent wheezing and prematurity were associated with lower respiratory tract involvement and worse COVID-19 severity scores among children seeking ER care. This drove the demand for asthma drugs, which were also suggested to have certain protective properties against the virus. Therefore, the overall impact of the COVID-19 pandemic on the asthma drugs market was positive.

Various organic and inorganic developments have been adopted by companies in the asthma drugs market. Organic strategies adopted by the market players consist of product launches and product approvals, whereas inorganic growth strategies are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, contributing to the overall progress of the market. Additionally, growth strategies, such as acquisitions and partnerships, help the asthma drugs market players strengthen their clientele and expand their product portfolios. A few of the significant developments made by key market players are mentioned below:

In December 2021, AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) got approval in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Tezspire is a first-in-class biologic for severe asthma that acts at the top of the inflammatory cascade by targeting thymic stromal lymphopoietin (TSLP), an epithelial cytokine. It is the first and only biologic to consistently and significantly reduce asthma exacerbations across Phase II and III clinical trials, which included a broad population of severe asthma patients irrespective of key biomarkers, including blood eosinophil counts and allergic status, and fractional exhaled nitric oxide (FeNO).

In November 2021, AstraZeneca agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis Pharma). The agreement ensured continued patient access to these established medicines. Covis Pharma previously acquired the rights to the respiratory medicines Alvesco, Omnaris, and Zetonna from AstraZeneca in 2018.

A few of the major primary and secondary sources referred to while preparing the report on the asthma drugs market are information bulletins, statistics, and press releases from Asthma & Allergy Foundation of America (AAFA), World Health Organization (WHO), European Respiratory Society (ERS), and the Centers for Disease Control and Prevention (CDC).

Online Pharmacies Segment to witness the highest growth in Asthma Drugs Market During 2021–2028

According to our latest study, "Asthma Drugs Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Medications, Route of Administration, and Distribution Channels," the asthma drugs market size is projected to grow from US$ 24,239.17 million in 2021 to US$ 34,136.10 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments.

Asthma is a chronic respiratory disease blocking the lungs' airways because of inflammation, mucus production, and tightening of muscles. Asthma can usually be managed with rescue inhalers to treat symptoms (salbutamol) and controller inhalers that prevent symptoms (steroids). Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium) and inhalant steroids. The growing incidence of asthma and other breathing syndromes is one of the significant elements increasing the market's progress. The growth of the asthma drugs market is primarily attributed to the growing environmental implications & genetic implications of air pollution and more vulnerability in specific ethnic groups. On the other hand, unmet medical needs and lack of treatment adherence are hindering the market's growth

Based on distribution channels, the asthma drugs market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. Online pharmacies are expected to witness the highest growth over the forecast period. The internet unquestionably impacted every part of our lives, including work, learning, and purchasing. The recent global pandemic of COVID-19 strengthened the position of digital commerce, which experienced rapid and sustained growth. The second COVID-19 wave increased sales by 25-65% for online pharmacies in India. Online sales also increased in countries such as the Czech Republic, Slovakia, and Nigeria. Furthermore, 70% of Czechs made at least one online purchase in their lives and nearly 59% in the last 12 months; in Slovakia, 63%of citizens aged 16 to 74 made an online purchase in the last year. The sales of online pharmacies for asthma products are expected to increase tremendously over the next few years due to the continued prevalence of COVID-19. Asthma patients prefer ordering medications online due to the fear of being exposed to the virus and the dread of insufficient availability.

AstraZeneca; TEVA PHARMACEUTICAL INDUSTRIES LTD; GlaxoSmithKline plc; Boehringer Ingelheim International GmbH; Merck & Co., Inc; Koninklijke Philips N.V.; Sanofi, Pfizer Inc. (Arena Pharmaceutical GmbH); Novartis AG; and Abbott are among the key players operating in the asthma drugs market.

Asthma Drugs Market, by Distribution Channel, 2021 (%)

Source: The Insight Partners Analysis

The report segments the Asthma Drugs market as follows:

Based on medications, the asthma drugs market is segmented into quick relief medications and long-term control medications. Based on route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. Based on distribution channels, the asthma drugs market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. Based on geography, the asthma drugs market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Asthma Drugs Market – By Medication

1.3.2 Global Asthma Drugs Market – By Route of Administration

1.3.3 Global Asthma Drugs Market – By Distribution Channel

1.3.4 Global Asthma Drugs Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Asthma Drugs Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South and Central America– PEST Analysis

4.3 Expert Opinion

5. Asthma Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Environmental Implications & Genetic Implications of Air Pollution

5.1.2 More Vulnerability in Specific Ethnic Groups

5.1.3 Growing Exposure to Coarse Particulate Matters

5.1.4 Growing Prevalence of Physiological Disorders Harboring Asthma

5.2 Market Restraints

5.2.1 Unmet Medical Needs

5.2.2 Lack of Treatment Adherence

5.3 Market Opportunities

5.3.1 Opportunities with Commercialization of Biologics

5.4 Future Trends

5.4.1 Increasing Research Activities and Product Innovations

5.5 Impact Analysis

6. Asthma Drugs Market– Global Analysis

6.1 Global Asthma Drugs Market Revenue Forecast and Analysis

6.1.1 Global Asthma Drugs Market Revenue Forecast and Analysis

6.1.2 Global Asthma Drugs Market Revenue Forecast and Analysis

6.1.3 Global Asthma Drugs Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance of Key Players

6.2.4.1 Pfizer Inc.

6.2.4.2 GlaxoSmithKline plc

7. Asthma Drugs Market Analysis – by Medication

7.1 Overview

7.2 Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

7.3 Quick Relief Medications

7.3.1 Overview

7.3.2 Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Long-term Control Medications

7.4.1 Overview

7.4.2 Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

8. Asthma Drugs Market Analysis – By Route of Administration

8.1 Overview

8.2 Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)

8.3 Inhaled

8.3.1 Overview

8.3.2 Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.4 Prefilled Syringe/Vials

8.4.1 Overview

8.4.2 Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.5 Others (Oral, Nasal, Ophthalmic Etc.)

8.5.1 Overview

8.5.2 Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9. Asthma Drugs Market Analysis – By Distribution Channel

9.1 Overview

9.2 Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)

9.3 Online Pharmacies

9.3.1 Overview

9.3.2 Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.4 Hospital Pharmacies

9.4.1 Overview

9.4.2 Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.5 Retail Pharmacies and Drugstores

9.5.1 Overview

9.5.2 Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10. Asthma Drugs Market – Geographical Analysis

10.1 North America: Asthma Drugs Market Revenue and Forecast to 2028

10.1.1 Overview

10.1.2 North America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.4 North America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.5 North America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6 North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2 US: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.1.3 US: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.1.4 US: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.2 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2 Canada: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.2.3 Canada: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.2.4 Canada: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.3 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2 Mexico: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.3.3 Mexico: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.3.4 Mexico: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2 Europe

10.2.1 Overview

10.2.2 Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.4 Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.5 Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6 Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.1 Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.2 Germany: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.1.3 Germany: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.1.4 Germany: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6.2 UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.1 UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.2 UK: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.2.3 UK: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.2.4 UK: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6.3 France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.1 France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.2 France: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.3.3 France: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.3.4 France: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6.4 Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.1 Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.2 Italy: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.4.3 Italy: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.4.4 Italy: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6.5 Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.1 Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.2 Spain: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.5.3 Spain: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.5.4 Spain: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6.6 Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.1 Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.2 Rest of Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.2.6.6.3 Rest of Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.2.6.6.4 Rest of Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.3 Asia Pacific: Asthma Drugs Market

10.3.1 Overview

10.3.2 Asia Pacific: Asthma Drugs Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.3.4 Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.3.5 Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.3.6 Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

10.3.6.1 India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.1.1 India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.1.2 India: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.3.6.1.3 India: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.3.6.1.4 India: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.3.6.2 China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.2.1 China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.2.2 China: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.3.6.2.3 China: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.3.6.2.4 China: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.3.6.3 Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.3.1 Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.3.2 Japan: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.3.6.3.3 Japan: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.3.6.3.4 Japan: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.3.6.4 South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.4.1 South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.2 South Korea: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.4.3 South Korea: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.4.4 South Korea: Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.5 Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.5.1 Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.2 Australia: Asthma Drugs Market, by Medication– Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.5.3 Australia: Asthma Drugs Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.5.4 Australia: Asthma Drugs Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Thousand)

10.3.6.6 Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.6.1 Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.3.6.6.2 Rest of Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.3.6.6.3 Rest of Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.3.6.6.4 Rest of Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.4 Middle East & Africa: Asthma Drugs Market

10.4.1 Middle East & Africa: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10.4.2 Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.4.3 Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.4.4 Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.4.5 Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

10.4.5.1 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.1.1 Overview

10.4.5.1.2 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.1.3 UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

10.4.5.1.3.1 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

10.4.5.1.3.2 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)

10.4.5.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.2.1 Overview

10.4.5.2.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.2.3 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

10.4.5.2.3.1 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

10.4.5.2.3.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)

10.4.5.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.3.1 Overview

10.4.5.3.2 South Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

10.4.5.3.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

10.4.5.3.3.1 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

10.4.5.3.3.2 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)

10.4.5.4 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.4.5.4.1 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

10.4.5.4.2 Rest of Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)

10.4.5.4.3 Rest of Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

10.4.5.4.4 Rest of Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

10.5 South and Central America: Asthma Drugs Market Revenue and Forecast to 2028

10.5.1 Overview

10.5.2 South and Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.3 South and Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.5.4 South and Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.5.5 South and Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.6 South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.2 Brazil: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.5.6.1.3 Brazil: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.5.6.1.4 Brazil: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.6.2 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.2 Argentina: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.5.6.2.3 Argentina: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.5.6.2.4 Argentina: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.6.3 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.1 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.2 Rest of South & Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.5.6.3.3 Rest of South & Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.5.6.3.4 Rest of South & Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Asthma Drugs Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Asthma Drugs Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Asthma Drugs Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 AstraZeneca

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GlaxoSmithKline plc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boehringer Ingelheim International GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Merck & Co., Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Koninklijke Philips N.V.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sanofi

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Pfizer Inc. (Arena Pharmaceutical GmbH)

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Novartis AG

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Abbott

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma

Table 2. Asthma Death Rates for Select Countries, 2018

Table 3. Common SABAs

Table 4. Commonly inhaled corticosteroids

Table 5. North America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 6. North America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 7. North America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8. US: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 9. US: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10. US: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13. Canada: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 17. Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 18. Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19. Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 20. Germany: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 21. Germany: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 22. Germany: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 23. UK: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 24. UK: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 25. UK: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 26. France: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 27. France: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 28. France: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 29. Italy: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 30. Italy: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 31. Italy: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 32. Spain: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 33. Spain: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 34. Spain: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 38. Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 39. Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 40. Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 41. India Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 42. India Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 43. India Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 44. China Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 45. China Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 46. China Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 47. Japan Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 48. Japan Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 49. Japan Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 50. South Korea Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

Table 51. South Korea Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

Table 52. South Korea Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 53. Australia Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)

Table 54. Australia Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)

Table 55. Australia Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 56. Rest of Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 57. Rest of Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 58. Rest of Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 59. Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 60. Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 61. Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 62. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

Table 63. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 64. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 65. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

Table 66. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 67. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 68. South Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)

Table 69. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 70. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 71. Rest of Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 72. Rest of Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 73. Rest of Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 74. South and Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 75. South and Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 76. South and Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 77. Brazil: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 78. Brazil: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 79. Brazil: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 80. Argentina: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 81. Argentina: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 82. Argentina: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 83. Rest of South & Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 84. Rest of South & Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 85. Rest of South & Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 86. Organic Developments in the Asthma Drugs Market

Table 87. Inorganic Developments in the Asthma Drugs Market

Table 88. Glossary of Terms, Asthma Drugs Market

LIST OF FIGURES.

Figure 1. Asthma Drugs Market Segmentation

Figure 2. Asthma Drugs Market, By Geography

Figure 3. Global Asthma Drugs Market Overview

Figure 4. The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Asthma Drugs Market, by Geography (US$ Million)

Figure 7. Global Asthma Drugs Market- Leading Country Markets (US$ Million)

Figure 8. Global Asthma Drugs Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East & Africa PEST Analysis

Figure 13. South and Central America PEST Analysis

Figure 14. Expert Opinion

Figure 15. Impact of Low Mood/Anxiety on Asthma

Figure 16. Adherence to ICS or ICS/LABA

Figure 17. Asthma Drugs Market Impact Analysis of Drivers and Restraints

Figure 18. Global Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028

Figure 19. Global Asthma Drugs Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 20. Global Asthma Drugs Market – Market Potential Analysis, By Region

Figure 21. Market Positioning of Key Players in Global Asthma Drugs Market

Figure 22. Global Asthma Drugs Market – Comparative Company Analysis

Figure 23. Global Asthma Drugs Market – Growth Strategy Analysis

Figure 24. Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

Figure 25. Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)

Figure 28. Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 29. Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 30. Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 31. Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)

Figure 32. Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 33. Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 34. Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 35. North America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. North America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 37. North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 38. Prevalence of Asthma by Age, Sex, and Race/Ethnicity, 2019

Figure 39. US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Prevalence of Diagnosed Asthma Among Canadians (%), By Age Group and Sex, 2011-12

Figure 41. Age-Standardized Prevalence of Diagnosed Asthma Among Canadians, by Sex and Year

Figure 42. Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 44. Europe: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 45. Europe: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 46. Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 47. Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 48. UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 52. Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 53. Asia Pacific: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 54. Asia Pacific Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 55. Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

Figure 56. India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 57. China Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 58. Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 59. South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 60. Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 61. Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 62. Middle East & Africa: Asthma Drugs Market, by Key Country – Revenue (2020) (USD Million)

Figure 63. Middle East & Africa Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 64. Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)

Figure 65. UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 66. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

Figure 67. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)

Figure 68. Rest of Middle East & Africa Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 69. South and Central America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 70. South and Central America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 71. South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 72. Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 73. Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 74. Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 75. Symptomatic Assessment to Differentiate Between COVID-19, Asthma, Flu, Cold, and Seasonal Allergies

Figure 76. Impact of COVID-19 Pandemic in North American Country Markets

Figure 77. Impact of COVID-19 Pandemic in European Country Markets

Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Countries

Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 80. Impact of COVID-19 Pandemic in South & Central American Country Markets

Figure 81. Growth Strategies in the Asthma Drugs Market (%)

The List of Companies - Asthma Drugs Market

1. AstraZeneca

2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

3. GlaxoSmithKline plc

4. Boehringer Ingelheim International GmbH

5. Merck & Co., Inc.

6. Koninklijke Philips NV

7. Sanofi

8. Pfizer Inc.

9. Novartis AG

10. Abbott

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the asthma drugs market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global asthma drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TOP